EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel tetrahedral framework nucleic acid‐derived chemodynamic therapy agent for effective glioblastoma treatment

Xiaodie Li, Lei Li, Xin Fu, Shiqian Huang, Yuhao Wang, Yuepeng Yang, Shuqin Zhou, Zhaowei Zou, Qing Peng, Chao Zhang iD

Cell Proliferation · 2025-01 · 58 (1)

DOI: 10.1111/cpr.13736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, online erschienen am 24.08.2024. Verfasst von Xiaodie Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Glioblastoma, Nucleic Acids, Hydrogen Peroxide. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Science and Technology Program of Guangzhou, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemodynamic therapy (CDT) has garnered significant attention for treating diverse malignant tumours due to its minimally invasive nature, reduced damage to healthy tissues, and potential mitigation of side effects. However, its application in glioblastoma (GBM) is hindered by the diminished capacity of CDT agents to traverse the blood–brain barrier (BBB), inadequate tumour targeting efficiency, and restricted availability of H 2 O 2 within the tumour microenvironment (TME). To address these challenges, we devised a novel CDT agent (Fe@tFNAs‐ANG‐3AT) based on a tetrahedral framework nucleic acids (tFNAs). Fe@tFNAs‐ANG‐3AT was constructed by anchoring iron ions (Fe 3+ ) onto the dual appendages‐modified tFNAs. Specifically, one appendage, Angiopep‐2 (ANG, a penetrating peptide), facilitates Fe@tFNAs‐ANG‐3AT penetration across the BBB and selective targeting of tumour cells. Simultaneously, the second appendage, 3‐Amino‐1,2,4‐triazole (3AT, a H 2 O 2 enzyme inhibitor), augments the H 2 O 2 levels required for effective CDT treatment. Upon tumour cell internalization, the loaded Fe 3+ in Fe@tFNAs‐ANG‐3AT is reduced to Fe 2+ by the overexpressed glutathione (GSH) in the TME, catalysing the generation of cytotoxic hydroxyl radicals (·OH) and inducing tumour cell death via elevated oxidative stress levels within tumour cells. It is anticipated that Fe@tFNAs‐ANG‐3AT holds promise as a transformative treatment strategy for GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNucleic AcidsHydrogen PeroxideHumansCell Line, TumorAnimalsBlood-Brain BarrierBrain NeoplasmsTumor MicroenvironmentIronMiceTriazolesAntineoplastic AgentsPeptides

Substanzen

Nucleic AcidsHydrogen PeroxideIronAngiopep-2TriazolesAntineoplastic AgentsPeptides

Autor:innen und Institutionen

  • Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Clinical Research Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Anesthesiology of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, China.
  • Central Laboratory of The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, China.

ORCID-Profile: Chao Zhang

Förderung

  • the National Natural Science Foundation of China
  • Science and Technology Program of Guangzhou
  • Guangdong Basic and Applied Basic Research Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Li, X., Li, L., Fu, X., Huang, S., Wang, Y., Yang, Y., Zhou, S., Zou, Z., Peng, Q., & Zhang, C. (2025). A novel tetrahedral framework nucleic acid‐derived chemodynamic therapy agent for effective glioblastoma treatment. Cell Proliferation, 58(1). https://doi.org/10.1111/cpr.13736

Vancouver

Li X, Li L, Fu X, Huang S, Wang Y, Yang Y, et al. A novel tetrahedral framework nucleic acid‐derived chemodynamic therapy agent for effective glioblastoma treatment. Cell Proliferation. 2025;58(1). doi:10.1111/cpr.13736

BibTeX
@article{Li2025,
  author = {Li, Xiaodie and Li, Lei and Fu, Xin and Huang, Shiqian and Wang, Yuhao and Yang, Yuepeng and Zhou, Shuqin and Zou, Zhaowei and Peng, Qing and Zhang, Chao},
  title = {A novel tetrahedral framework nucleic acid‐derived chemodynamic therapy agent for effective glioblastoma treatment},
  journal = {Cell Proliferation},
  year = {2025},
  volume = {58},
  number = {1},
  doi = {10.1111/cpr.13736}
}
Kostenlos starten →